All articles tagged with #ai tool
Maxon has introduced a standalone AI-powered tool called Maxon Digital Twin (MDT) designed for creating digital representations of physical objects for marketing and commercial use. The company clarified that MDT uses a third-party AI agent, not trained on user works, and plans to integrate with other AI-enabled graphic apps, raising questions about future AI tools across its product lineup.
Microsoft's stock (NASDAQ:MSFT) rose following the release of a new, unusual AI tool, indicating positive market sentiment towards the company's innovative developments.
The U.S. DOGE Service is developing an AI tool called the 'DOGE AI Deregulation Decision Tool' to analyze and eliminate approximately 100,000 federal regulations, aiming to cut half of Washington's regulatory mandates within a year, potentially saving trillions of dollars and reducing compliance burdens.
The FDA's new AI tool, CDRH-GPT, still in beta, faces significant issues such as bugs, connectivity problems, and inaccuracies, raising concerns about rushing AI deployment in medical device review processes amid staff layoffs and safety considerations.
The FDA has launched an agencywide generative AI tool called Elsa to streamline scientific reviews, support drug safety assessments, and improve efficiency, while emphasizing secure data handling within Amazon Web Services' GovCloud environment. Concerns remain about data security and the speed of AI integration into the agency's workflow.
The FDA has launched its agency-wide AI tool, Elsa, ahead of schedule, aiming to streamline clinical protocol reviews and speed up regulatory processes, as highlighted by Commissioner Marty Makary.
Perplexity has launched Perplexity Labs, an AI-powered tool for subscribers that can generate reports, spreadsheets, dashboards, and more, expanding beyond its core search business and available across multiple platforms.
Doctors have developed an AI tool to predict side-effects in breast cancer patients after treatment, aiming to provide more personalized care and support. The tool, trained using data from 6,361 patients, can predict lymphoedema with 73.4% accuracy and identify patients at higher risk of arm swelling, allowing for alternative treatments or additional support. The AI tool is being trialled in the UK, France, and the Netherlands and is part of a clinical trial called the Pre-Act project. Additionally, researchers have found that combined PET-MRI scans can help detect tumour spread, while low-dose boost radiotherapy has shown promise in preventing local recurrence in young breast cancer patients.
Google is developing an AI tool for news publishers that can generate article text and headlines, aiming to enhance journalists' work and productivity. The project, referred to as "Genesis," has been pitched to media companies such as The New York Times, The Washington Post, and News Corp. Google clarified that the tool is not intended to replace journalists but to assist them. However, concerns have been raised about the accuracy of AI-generated content.
Customer support agents using a Generative Pre-trained Transformer (GPT) AI tool saw a nearly 14 percent increase in productivity, with 35 percent improvements for the lowest skilled and least experienced workers, and zero or small negative effects on the most experienced/most able workers. The AI tool offered potential responses to customer queries, and agents could choose to take those suggestions or ignore them and enter their own responses. The tool helped newer and lower skilled workers adopt the skills and behavior of more experienced workers more quickly, and customers were more likely to express positive sentiments when interacting with agents using AI assistance.
Researchers from Google, MIT, and the University of Pennsylvania have developed DragGAN, a photo editing app that uses AI to manipulate images by dragging two main components. The AI tool regenerates areas of the image that did not exist before, allowing for precise control over the pose, shape, expression, and layout of diverse categories such as animals, cars, humans, and landscapes. The approach explores a new way of manipulating generative adversarial networks (GANs) and shows a lot of promise, with the ability to hallucinate occluded content and deform following the object's rigidity.
An AI tool has been developed that can predict Parkinson's disease with up to 96% accuracy and up to 15 years before a clinical diagnosis based on the analysis of chemicals in blood. The tool also identified key metabolites that were strongly linked to a correct prediction. Parkinson's is the world's fastest-growing neurological disease, and symptoms such as depression, loss of smell, and sleep problems can predate clinical movement or cognitive symptoms by decades. The disease has no specific test and cannot be accurately diagnosed before motor symptoms appear.
Korean developer Ironmace, accused of copyright infringement by Nexon, has used an AI chatbot to prove that the premise of its upcoming game, Dark and Darker, is generic and can be applied to numerous other fantasy games. Ironmace has also claimed that the former Nexon employee who leaked company data and assets was fired based on unproven claims. Ironmace has proof it has done nothing untoward during the development of Dark and Darker and has requested that Nexon renounce its baseless claims.
Valve announced the surprise release of Counter-Strike 2 this summer, which will be available for free as an update to Counter-Strike: Global Offensive. Redfall's always online requirement may be removed if the developers can find a fix, and Ubisoft has unveiled an AI tool to help with smaller writing duties, which has been met with skepticism.